Implications of the allosteric kinetics of cytochrome P450s

被引:40
作者
Atkins, WM [1 ]
机构
[1] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA
关键词
D O I
10.1016/S1359-6446(04)03072-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Drug metabolites can uniquely contribute to therapeutic efficacy, toxicity and drug-drug interactions. Therefore, the rates of formation and clearance of each metabolite are crucially important parameters in the net therapeutic profile of new drugs. However, the recent appreciation for the importance of drug metabolism has made it apparent that the understanding of the fundamental kinetic and biophysical properties of the enzymes that are responsible for catalyzing these reactions, the cytochrome P450s, is incomplete. The need to fully comprehend the complex allosteric behavior of these enzymes has fostered increased scrutiny of cytochrome P450s, which has subsequently resulted in major changes in the way that these enzymes are perceived at the molecular level.
引用
收藏
页码:478 / 484
页数:7
相关论文
共 51 条
[1]   Is there a toxicological advantage for non-hyperbolic kinetics in cytochrome P450 catalysis? Functional allostery from "distributrve catalysis" [J].
Atkins, WM ;
Lu, WYD ;
Cook, DL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (36) :33258-33266
[2]   CYTOCHROME-P450 AND AROMATIC BASES - A H-1-NMR STUDY [J].
BANCI, L ;
BERTINI, I ;
MARCONI, S ;
PIERATTELLI, R ;
SLIGAR, SG .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1994, 116 (11) :4866-4873
[3]   Enhanced detoxication due to distributive catalysis and toxic thresholds: A kinetic analysis [J].
Cook, DL ;
Atkins, WM .
BIOCHEMISTRY, 1997, 36 (36) :10801-10806
[4]   Crystal structures of ligand complexes of P450eryF exhibiting homotropic cooperativity [J].
Cupp-Vickery, J ;
Anderson, R ;
Hatziris, Z .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3050-3055
[5]   Pyrene-pyrene complexes at the active site of cytochrome P450 3A4: Evidence for a multiple substrate binding site [J].
Dabrowski, MJ ;
Schrag, ML ;
Wienkers, LC ;
Atkins, WM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (40) :11866-11867
[6]   Phenylalanine and tryptophan scanning mutagenesis of CYP3A4 substrate recognition site residues and effect on substrate oxidation and cooperativity [J].
Domanski, TL ;
He, YA ;
Khan, KK ;
Roussel, F ;
Wang, QM ;
Halpert, JR .
BIOCHEMISTRY, 2001, 40 (34) :10150-10160
[7]   Generation and evaluation of a CYP2C9 heteroactivation pharmacophore [J].
Egnell, AC ;
Eriksson, C ;
Albertson, N ;
Houston, B ;
Boyer, S .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 307 (03) :878-887
[8]   In vivo CYP3A4 heteroactivation is a possible mechanism for the drug interaction between felbamate and carbamazepine [J].
Egnell, AC ;
Houston, B ;
Boyer, S .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 305 (03) :1251-1262
[9]  
Ekins S, 1998, J PHARMACOL EXP THER, V286, P1253
[10]  
Ekins S, 1998, INT J CLIN PHARM TH, V36, P642